Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OSBPL10 antisense RNA 1 (OSBPL10-AS1) is a non-protein coding long non-coding RNA located adjacent to the OSBPL10 gene on chromosome 3. Its sequence has been reported in genome databases, but there is currently minimal experimental evidence or literature describing its specific biological function, molecular interactions, or clinical significance. Unlike the OSBPL10 protein, which participates in lipid metabolism, immune regulation, and has been studied in contexts such as dengue virus replication and cancer, OSBPL10-AS1 remains a poorly characterized transcript with no known therapeutic targeting, disease association, or drug interactions. Its primary significance lies in being part of the genomic region adjacent or overlapping with the OSBPL10 gene, potentially contributing to regulation at the RNA level, but explicit roles and functions remain to be defined[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OSBPL10 antisense RNA 1 (OSBPL10-AS1).